The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis
- PMID: 3060046
- DOI: 10.1007/BF01310824
The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis
Abstract
The gerbil, Meriones unguiculatus, was investigated as a model for the encephalitic form of Rift Valley fever. Resistance to necrotizing encephalitis was age-dependent with 100% mortality at 3 weeks, decreasing to approximately 20% by 10 weeks of age in outbred gerbils inoculated subcutaneously. Fatal encephalitis in the 10-week-old adults was dose-independent [1.0-7.0 log10 plaque forming units (PFU), subcutaneously]. Viral replication and histological lesions were followed serially throughout the course of the infection in young (4 week) and adult (10 week) gerbils. Viral replication was evident in the brain tissue of young gerbils from day 4 (3.0 log10 PFU/g) through day 7 (6.0 log10 PFU/g), the last day the young gerbils survived. Virus was only detected in the brain tissue of a single adult gerbil (day 7, 4.0 log10 PFU/g) of 26 studied in the sequential survey. In contrast, two moribund adult gerbils had approximately 7.0 log10 PFU/g of virus in the brain tissue on days 8 and 11. When young and adult gerbils were inoculated with a low dose (50 PFU) of virus intracranially, there were no detectable differences in the course of infection with all animals succumbing to fatal necrotizing encephalitis approximately 7 days postinoculation. The young gerbil becomes the first animal model in which uniformly fatal RVFV-induced encephalitis is produced without significant extraneural lesions.
Similar articles
-
Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats.Microb Pathog. 1987 Apr;2(4):283-93. doi: 10.1016/0882-4010(87)90126-4. Microb Pathog. 1987. PMID: 3509859
-
Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.Virology. 2019 Jan 2;526:173-179. doi: 10.1016/j.virol.2018.10.021. Epub 2018 Nov 2. Virology. 2019. PMID: 30396029 Free PMC article.
-
Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model.PLoS Negl Trop Dis. 2014 Jun 12;8(6):e2874. doi: 10.1371/journal.pntd.0002874. eCollection 2014 Jun. PLoS Negl Trop Dis. 2014. PMID: 24922480 Free PMC article.
-
Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.Virus Res. 2016 May 2;216:55-65. doi: 10.1016/j.virusres.2015.05.012. Epub 2015 May 27. Virus Res. 2016. PMID: 26022573 Free PMC article. Review.
-
Rift Valley fever.Adv Vet Sci Comp Med. 1983;27:347-425. Adv Vet Sci Comp Med. 1983. PMID: 6359835 Review. No abstract available.
Cited by
-
Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters.Arch Virol. 1990;114(3-4):203-12. doi: 10.1007/BF01310749. Arch Virol. 1990. PMID: 2122875
-
Isolation of Borna disease virus from human brain tissue.J Virol. 2000 May;74(10):4601-11. doi: 10.1128/jvi.74.10.4601-4611.2000. J Virol. 2000. PMID: 10775596 Free PMC article.
-
Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis.Annu Rev Virol. 2024 Sep;11(1):309-325. doi: 10.1146/annurev-virology-093022-011544. Epub 2024 Aug 30. Annu Rev Virol. 2024. PMID: 38635867 Review.
-
Molecular biology and genetic diversity of Rift Valley fever virus.Antiviral Res. 2012 Sep;95(3):293-310. doi: 10.1016/j.antiviral.2012.06.001. Epub 2012 Jun 16. Antiviral Res. 2012. PMID: 22710362 Free PMC article. Review.
-
A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.Sci Rep. 2018 Nov 20;8(1):17097. doi: 10.1038/s41598-018-35472-7. Sci Rep. 2018. PMID: 30459418 Free PMC article.
References
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical